Potassium Chloride Extended Release Tablets
Award NoticeNo Set AsideAwarded
This federal contract opportunity has been awarded to on October 16, 2025.
Award Information
This solicitation resulted in an award to for approximately $39,510,149 on October 16, 2025. Similar contracts are typically issued by DEPT OF DEFENSE under 325412 (Pharmaceutical Preparation Manufacturing).
- Award Number
- SPE2D2-26-D-0001
- Award Amount
- $39,510,149
- Award Date
- October 16, 2025
Key Takeaways
- No response deadline specified - contact the agency for details
- Set-aside for No Set Aside businesses
- Work to be performed in PHILADELPHIA, PA
- Industry: Pharmaceutical Preparation Manufacturing
Contract Details
- Notice ID
- SPE2D2-26-D-0001
- Opportunity Type
- Award Notice
- Agency
- DEPT OF DEFENSE
- Sub-Agency
- DEFENSE LOGISTICS AGENCY
- Office
- DLA TROOP SUPPORT
- Posted Date
- Thursday, March 19, 2026
- Response Deadline
- Not specified
- PSC Code
- 6505
- Set-Aside
- No Set Aside
- Place of Performance
- PHILADELPHIA, PA, 19111
- Status
- Active
Description
SPE2D2-26-D-0001 Potassium Chloride ER Tablets
Why This Opportunity Matters
The Department of DEFENSE is seeking responses for pharmaceutical preparation manufacturing with a set-aside for No Set Aside businesses in PHILADELPHIA, PA. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
